CD8A and metabolic dysfunction-associated steatotic liver disease: Unexpectedly, the increase was even more dramatic in NAFLD mice (MCD low: 1.32% vs MCD high: 11.14%, p < 0.0001), and significantly more OVA257-264-specific CD8+ T cells were found in NAFLD mice as compared to normal diet mice having liver OVAhigh tumor (ND high: 5.90% vs MCD high: 11.14%, p < 0.0001) (ND high: 11.56% vs Ob high: 20.34%, p < 0.01) (Figures 3A and S2A).